NCBiotech News

We work hard to bring you the stories about the life science community in North Carolina. Every once in a while, we add a little news of our own. Read some of those stories below, or check out some of our perspectives on our staff blog.

Duke lab photo
Armed with federal grants and contracts totaling nearly $600 million, Duke has leased 273,000 square feet that will be retrofitted in the Parmer RTP research and development campus for vaccine development.
Shattuck Labs logo
Shattuck Labs is changing the face of cancer therapy, aided by $118 million Series B equity financing that will push its clinical research on cancer immunotherapy to the next level.
Santo Costa
Santo Costa, an attorney and long-time pharmaceutical executive, has been elected chairman of the North Carolina Biotechnology Center’s Board of Directors.
Durham's Bio Products Laboratory USA has launched two new plasma therapies covering six serious medical conditions, as it also works on developing a COVID-19 treatment.
FoodLogiQ computer view
Durham-based FoodLogiQ, is collaborating with three other food industry technology leaders to keep the food supply safer by identifying and tracking products, so food companies can respond faster, with better results, when safety issues arise.
PBA logo
Durham's Path BioAnalytics is teaming up with impact investors and a digital health company to find a cure for pancreatitis.
AAD lab and cattle
Advanced Animal Diagnostics is using a $50,000 grant from NCBiotech, through a program established by the Wells Fargo Foundation, to “repurpose” its blood test platform designed to detect disease in cattle, to add a screen for COVID-19 in humans.
Scott Soderling
NCBiotech provided a $250,000 loan to bootstrap CasTag BioSciences, a Duke spinout based on a technology that marks proteins in an entirely new way, using the genome-editing tool CRISPR. The resulting products are selling, and the potential is HiUGE.
Production worker at Grifols in Clayton
Grifols, a global biotherapeutics company with major operations in North Carolina, has begun producing the first specific COVID-19 drug at its manufacturing campus in Clayton.
Mycovia logo
“The future of biopharma is in females,” said Mycovia CEO Patrick Jordan earlier this week during a panel discussion at the BIO Digital life sciences conference.
Collaborations Pharma team
Raleigh's Collaborations Pharmaceuticals is partnering with universities, foundations and other companies to develop drugs that treat rare and neglected diseases, but it's also targeting COVID-19 now. 
ASU pollinator researchers
Appalachian State University faculty members have developed a free app to allow people around the world log the activity of bees and other pollinators.
BioMedInnovations SuppleVent ventilator
NC Med Tech Firm BioMedInnovations Gets FDA OK for Innovative COVID-19 Ventilator Developed wIth Rare Partnerships, from NASCAR to Lawrence Livermore
MedPharm lab facility in RTP
UK-based MedPharm Ltd., which completed a $4 million expansion in Research Triangle Park just six months ago, is at it again, this time in Durham.
Aerial view of Grifols Clayton campus
Grifols, a global biotherapeutics company with more than 2,000 employees in North Carolina, is adding 300 more to its Clayton workforce as part of a $351.6 million expansion there.